Ryuji Yamaguchi

Summary

Publications

  1. ncbi Finding a Panacea among combination cancer therapies
    Ryuji Yamaguchi
    Kyushu University Medical School, Fukuoka, Japan
    Cancer Res 72:18-23. 2012
  2. ncbi Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy
    Ryuji Yamaguchi
    Program of Cell Death and Apoptosis, Sanford Burnham Medical Research Institute, La Jolla, California, United States of America
    PLoS ONE 6:e24102. 2011

Collaborators

Detail Information

Publications2

  1. ncbi Finding a Panacea among combination cancer therapies
    Ryuji Yamaguchi
    Kyushu University Medical School, Fukuoka, Japan
    Cancer Res 72:18-23. 2012
    ..Because ABT directly triggers apoptosis at the step very near the terminal point of apoptosis, 2DG-ABT combination therapies are applicable to many types of cancer at all stages of development, with little side effect...
  2. ncbi Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy
    Ryuji Yamaguchi
    Program of Cell Death and Apoptosis, Sanford Burnham Medical Research Institute, La Jolla, California, United States of America
    PLoS ONE 6:e24102. 2011
    ....